|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.430 EUR | -3.38% |
|
+11.59% | +107.01% |
| 07-09 | THX Pharma secures its financial roadmap |  |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
| Market Cap | 63.26M 72.89M 59.23M 54.18M 102M 6.94B 104M 693M 272M 3.47B 274M 268M 11.55B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 39.56M 45.58M 37.04M 33.88M 63.97M 4.34B 64.8M 433M 170M 2.17B 171M 167M 7.22B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.38% | ||
| 1 week | +11.59% | ||
| Current month | +3.02% | ||
| 1 month | +20.38% | ||
| 3 months | +27.30% | ||
| 6 months | +94.30% | ||
| Current year | +107.01% |
| 1 week | 4.1 |  | 4.7 |
| 1 month | 3.36 | | 4.7 |
| Current year | 1.83 | | 5.1 |
| 1 year | 1.49 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 9.27 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2023 | |
Christine Placet
DFI | Director of Finance/CFO | - | 01/04/2024 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/2024 | |
| Chairman | - | 31/03/2024 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/04/26 | Buy | Chief Operating Officer | 4,944 | 0.0342% | ||
| 28/01/21 | Sell | Chief Financial Officer | 750 | 0.0207% | ||
| 28/01/21 | Sell | Chief Financial Officer | 1,000 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.38% | +11.59% | +34.24% | +254.97% | 73.04M | |
| -3.25% | +12.81% | +52.96% | +88.86% | 64.9B | |
| +0.69% | -2.81% | +25.84% | +68.41% | 54.05B | |
| -1.12% | -2.44% | -18.61% | -8.04% | 23.16B | |
| +31.45% | +28.50% | +17.22% | +496.32% | 21.46B | |
| +1.87% | +5.08% | +29.88% | -7.94% | 21.25B | |
| -0.79% | +1.79% | +36.31% | -26.13% | 17.94B | |
| -3.37% | +19.44% | +211.98% | +369.13% | 17.03B | |
| +3.29% | +2.09% | +17.32% | +586.49% | 14.99B | |
| -8.69% | -6.24% | +39.15% | +159.14% | 14.25B | |
| Average | +1.61% | +4.58% | +44.63% | +198.12% | 24.91B | |
| Weighted average by Cap. | +1.42% | +3.64% | +42.11% | +147.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.71M 11.14M 10.19M 19.24M 1.31B 19.49M 130M 51.16M 653M 51.49M 50.37M 2.17B | 4.3M 4.96M 4.03M 3.68M 6.95M 472M 7.04M 47.11M 18.49M 236M 18.6M 18.2M 785M |
| Net Debt | -23.7M -27.31M -22.19M -20.3M -38.32M -2.6B -38.82M -260M -102M -1.3B -103M -100M -4.33B | -27.4M -31.57M -25.66M -23.47M -44.31M -3.01B -44.89M -300M -118M -1.5B -119M -116M -5B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | €4.430 | -3.38% | 186,194 |
| 05/08/26 | €4.585 | +1.44% | 90,252 |
| 04/08/26 | €4.520 | +5.85% | 267,405 |
| 03/08/26 | €4.270 | -0.70% | 154,595 |
| 31/07/26 | €4.300 | +4.62% | 359,136 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.585EUR
Average target price
5.800EUR
Spread / Average Target
+26.50%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
